James Cook, MD, PhD
Hematopathology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout James Cook
Biography
James R. Cook, M.D., Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine. He serves as Section Head of Hematopathology in the Department of Laboratory Medicine. Dr. Cook's clinical interests focus on diagnostic hematopathology and molecular diagnostics.
His research interests include diagnostic and prognostic markers in non-Hodgkin lymphoma and plasma cell disorders, and molecular diagnosis of leukemia and lymphoma. He participates in numerous multi-institutional research efforts including the Lymphoma and Leukemia Molecular Profiling Project (LLMPP) and the Lymphoma Translational Medicine Committee for SWOG. He regularly serves as faculty for post-graduate educational courses at national and international meetings.
Education & Board Certifications
Education
- Fellowship: University of Pittsburgh School of Medicine, 2003
- Residency: Barnes Jewish Hospital, 2001
- Medical Education: Washington University School of Medicine, 1998
- Graduate School: Washington University School of Medicine, 1998
- Undergraduate: Pennsylvania State University, 1991
Board Certifications
- Hematopathology: American Board of Pathology, 2004
- Anatomic Pathology: American Board of Pathology, 2001
Professional Highlights
- President, Society for Hematopathology, 2020-2022
- Chair, Association for Molecular Pathology Hematopathology Subdivision, 2011-2012
- Member of Lymphoma Translational Medicine Committee, Southwest Oncology Group
Awards
- Pathologist-in-Training Award, Society for Hematopathology, 2003
- John Beach Hazard Distinguished Teacher Award, Institute of Pathology and Laboratory Medicine, 2005
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-12-08, Dr. Cook has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.